Charlottetown-based Somru BioScience has partnered with Veeda Clinical Research, an Indian contract research organization, to establish Ingenuity BioSciences, a new bioanalytical lab in Ahmedabad, India.
The two companies have taken equal stakes in the new facility, which will be led by Somru CEO Mohammed Moin and Ingenuity BioSciences CEO Ravi Krovidi.
“This relationship will allow us to leverage our extensive experience as a biosimilar solution provider in this fast-emerging Asian market,” said Moin in a statement. “We are very impressed with Veeda’s track record as an excellent clinical